1301 - 1325 of 9030 Results
Title
Year
-
OPENTitle: Nucleic Acid–Based Therapeutics for Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 52
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019OPENTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7011644Citation Count: 43
-
OPENTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7234797Citation Count: 53
-
OPENTitle: The complex role of inflammation and gliotransmitters in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 176Issue #:Start Page: 105940End Page: 105940Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105940Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105940Citation Count: 38
- Therapeutic approaches to cholinergic deficiency in Lewy body diseases2019RESTRICTEDTitle: Therapeutic approaches to cholinergic deficiency in Lewy body diseasesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 1Start Page: 41End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1676152Citation Count: 11
-
OPENTitle: Clinical Chronobiology: Circadian Rhythms in Health and DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 45Issue #: 03Start Page: 317End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1055/a-2538-3259Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12323393Citation Count: 2
-
OPENTitle: Targeting the proteostasis network in Huntington’s diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 49Issue #:Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2018.11.006Best OA location URL: https://doi.org/10.1016/j.arr.2018.11.006Citation Count: 78
-
OPENTitle: A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 11Start Page: 8129End Page: 8152Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14250Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14250Citation Count: 12
-
OPENTitle: Adapting the proteostasis capacity to sustain brain healthspanJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 6Start Page: 1545End Page: 1560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007Best OA location URL: http://www.cell.com/article/S0092867421001574/pdfCitation Count: 108
- Volitional Control of Brain Motor Activity and Its Therapeutic Potential2022RESTRICTEDTitle: Volitional Control of Brain Motor Activity and Its Therapeutic PotentialJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 8Start Page: 1187End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.007Citation Count: 14
-
OPENTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 68
-
OPENTitle: Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 164Issue #:Start Page: 105625End Page: 105625Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105625Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105625Citation Count: 7
-
OPENTitle: Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and managementJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 547End Page: 555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000955Best OA location URL: https://hal.science/hal-03298526Citation Count: 19
- Targeting the Dopaminergic System in Autoimmunity2019RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 72
- Suppression of Pain Sensation Caused by Millimeter Waves1999RESTRICTEDTitle: Suppression of Pain Sensation Caused by Millimeter WavesJournal Name: Anesthesia & AnalgesiaPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 4Start Page: 836End Page: 840Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1213/00000539-199904000-00029Citation Count: 33
-
OPENTitle: Immunotherapy in Parkinson’s disease: Current status and future directionsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104587End Page: 104587Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104587Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104587Citation Count: 66
-
OPENTitle: Investigating the ageing-Parkinson’s disease nexus: standardisation of in vitro models and techniques by the PD-AGE networkJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01137-2Best OA location URL: https://doi.org/10.1038/s41531-025-01137-2Citation Count: 0
-
OPENTitle: Endoplasmic Reticulum Membrane Contact Sites, Lipid Transport, and NeurodegenerationJournal Name: Cold Spring Harbor Perspectives in BiologyPublisher: Cold Spring Harbor LaboratoryVol: 15Issue #: 4Start Page: a041257End Page: a041257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/cshperspect.a041257Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10071438/pdf/cshperspect-ERT-a041257.pdfCitation Count: 35
-
OPENTitle: The Effects of Physical Activity in Parkinson’s Disease: A ReviewJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 4Start Page: 685End Page: 698Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160790Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160790?id=journal-of-parkinsons-disease%2Fjpd160790Citation Count: 201
-
OPENTitle: Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 5Start Page: 778End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22321Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082599Citation Count: 91
-
OPENTitle: Neurodegeneration with Brain Iron Accumulation: Diagnosis and ManagementJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 8Issue #: 1Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.14034Best OA location URL: https://doi.org/10.14802/jmd.14034Citation Count: 208
-
OPENTitle: Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2Journal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 40Issue #: 5Start Page: 1042End Page: 1046Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1042/bst20120112Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9112632Citation Count: 20
-
OPENTitle: Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug DiscoveryJournal Name: The AAPS JournalPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 167End Page: 177Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1208/s12248-009-9090-7Best OA location URL: http://doi.org/10.1208/s12248-009-9090-7Citation Count: 160
-
OPENTitle: Use of ibuprofen and risk of Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 10Start Page: 863End Page: 869Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820f2d79Best OA location URL: https://n.neurology.org/content/neurology/76/10/863.full.pdfCitation Count: 316
-
RESTRICTEDTitle: Turning the heterogeneous into homogeneous: studies on selectively isolated GABAergic interneuron subsetsJournal Name: International Journal of Developmental NeurosciencePublisher: WileyVol: 22Issue #: 7Start Page: 533End Page: 543Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ijdevneu.2004.07.012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.ijdevneu.2004.07.012Citation Count: 21